Moleculin Biotech, Inc. (MBRX) Total assets 2016–2025
Moleculin Biotech, Inc. (MBRX) total assets at each fiscal year-end, per SEC filings.
$22.1MFY2025 · since FY2016: $16.4M → $22.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $22.1M | +30.7% |
| FY2024 | $16.9M | -55.7% |
| FY2023 | $38.2M | -33.4% |
| FY2022 | $57.4M | -31.7% |
| FY2021 | $84.1M | +189.7% |
| FY2020 | $29.0M | +15.0% |
| FY2019 | $25.2M | +28.8% |
| FY2018 | $19.6M | +0.5% |
| FY2017 | $19.5M | +18.8% |
| FY2016 | $16.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MBRX financial trends
MBRX RevenueMBRX Net incomeMBRX Net marginMBRX Gross profitMBRX Gross marginMBRX Operating incomeMBRX Operating marginMBRX Operating cash flowMBRX Free cash flowMBRX Capital expendituresMBRX Return on equityMBRX Stock buybacksMBRX Dividends paidMBRX Total liabilitiesMBRX Shareholders’ equityMBRX overview →